Philips' MRI scanners are now compatible with Insightec technology to treat patients suffering with essential tremor (ET) and Parkinson's disease. Exablate Prime is able to be integrated with select, ...

Even the most basic movements like tying a pair of shoe laces, drinking a cup of coffee or snapping a selfie can be a daunting task for someone suffering from essential tremor. In the United States, ...

HAIFA, Israel and MIAMI, Fla., Dec. 1, 2021 /PRNewswire/ -- Insightec, a global healthcare company creating the next generation of patient care by realizing the therapeutic power of acoustic energy, ...

InSightec has announced it has received FDA approval for its ExAblate MRI guided focused ultrasound treatment of bone metastases in patients who are not candidates for or refuse to undergo radiation ...

Study of 101 patients found that Insightec' Exablate Prostate system is a safe and effective treatment option for intermediate risk prostate cancer. The Insightec Exablate Prostate system is the only ...

After it received expanded FDA approval for an incisionless surgical device, Insightec raised new funding that valued the company above $1 billion. The company closed a $150 million funding round for ...

Germany-based Insightec and Israel-based Siemens Healthineers entered into a strategic agreement to develop compatibility between Insightec's Exablate Neuro device and Siemans' clinical MRI systems.

Lotus Neuro builds on Insightec's groundbreaking focused ultrasound platform to accelerate next-generation brain therapies globally, with funding from Nexus NeuroTech Ventures. MIAMI and HAIFA, Israel ...

INSIGHTEC®,a global medical technology innovator of incisionless surgery, today announced that the U.S. Food and Drug Administration (FDA) has approved Exablate Neuro™ compatibility for the ...

InSightec Ltd., an Israel-based developer of magnetic resonance-guided focused ultrasound systems for the operating room, has raised $30 million in new VC funding. Return backers include Elbit ...